Kitazato Corporation (TYO:368A)

Japan flag Japan · Delayed Price · Currency is JPY
1,306.00
-10.00 (-0.76%)
Apr 28, 2026, 3:30 PM JST
-34.73%
Market Cap 52.24B
Revenue (ttm) 10.98B
Net Income (ttm) 3.98B
Shares Out 40.00M
EPS (ttm) 99.60
PE Ratio 13.11
Forward PE 13.14
Dividend 41.00 (3.14%)
Ex-Dividend Date Mar 30, 2026
Volume 488,300
Average Volume 128,980
Open 1,323.00
Previous Close 1,316.00
Day's Range 1,303.00 - 1,328.00
52-Week Range 1,295.00 - 2,158.00
Beta n/a
RSI 40.93
Earnings Date Apr 30, 2026

About Kitazato

Kitazato Corporation researches, develops, manufactures, and markets medical devices and related products for fertility treatment. It offers needles, catheters and cannulas, vitrification media and equipment, sperm processing medium/tools, IVF medium products, micro tools, and labware products. The company was formerly known as Kitazato Biopharma Co., Ltd. The company was founded in 1998 and is based in Shizuoka, Japan. Kitazato Corporation is a subsidiary of Kitasato Shoji Co., Ltd. [Read more]

Sector Healthcare
Founded 1998
Employees 86
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 368A
Full Company Profile

Financial Performance

In fiscal year 2025, Kitazato's revenue was 10.30 billion, an increase of 2.20% compared to the previous year's 10.08 billion. Earnings were 3.79 billion, a decrease of -4.63%.

Financial Statements

News

There is no news available yet.